BGC$11.27-0.6%Cap: $5.3BP/E: 36.452w: [========|--](Apr 25)
Setup
BGC Group trades at 7.04x forward P/E carrying ≈75% of FMX, the cash U.S. Treasury CLOB venue that has gained share from 30% to 39% of the market over six quarters. CME Group's Q1 2026 10-Q (filed April 24) — combined with reports from Tradeweb, ICE, and BGC's outlook preannouncement — produces four independent corroboration angles that the migration is structural, not cyclical. BGC's Q1 earnings on May 7 is the binary catalyst.
What the Filings Say
CME BrokerTec U.S. Treasury cash CLOB ADV declined -3.4% YoY in Q1 2026 ($107.9B vs $111.7B) — the third consecutive period of decline (FY2024→FY2025 was -5%). Q1 2026 was a HIGH-volatility quarter (Hormuz blockade, Iran war, oil $95-110). CLOB venues should benefit from vol; CME's went down anyway. Revenue rose +12% (higher notional per trade), masking the volume erosion.
Tradeweb's March 2026 monthly report: U.S. government bond ADV +24.4% YoY at a record $310.1B. ≈28-percentage-point relative spread between Tradeweb and CME in the same market over the same window.
ICE Clear Credit launched UST cash clearing operationally on February 3, 2026 — beating CME's CMESC by 11+ months on a December 31 SEC mandate deadline. CEO Duffy preempted CMESC delay risk on the Q1 call: "Sometimes you hear folks say this could be delayed — that's not a surprise."
BGC's March 26 8-K preannounced Q1 outlook above guidance high end ($222M+ PBT) and called FMX UST "the world's fastest growing U.S. cash treasuries platform."
CME mentioned FMX zero times on its Q1 earnings call — the fifth consecutive call without acknowledgment.
What the Market Thinks
BGC trades at 7.04x forward P/E. Mean analyst target $14.50 (9x forward, only 2 analysts covering). Comp set: CME 24x, ICE 28x, Tradeweb 30x. BGC traded 9-11x pre-FMX in 2022-2023.
Sum-of-parts mid: BGC IDB ex-FMX $2.5B + FMX (75% of $6B private comp) = ≈$7-10B → $14-19/share vs $11.27 market. Market is pricing FMX at near-zero incremental value.
Options: ATM IV 52.1% (119th percentile), OI P/C 0.09 (calls 10.9x puts), May 15 expiry. Market-implied P(positive print) ≈ 62%; we estimate 70%. Edge: 8pp on print, 13pp on 6-month rerate to ≥10x forward.
Why the Gap Exists
Cross-ticker synthesis requires reading four issuers' filings and connecting voice/CLOB/clearing data. Sell-side coverage is siloed — 25+ analysts on CME, 2 on BGC, none building cash UST market structure models that span all four venues.
CME's persistent silence on FMX (5 consecutive calls) starves the analyst community of the framing that would make FMX-share-gain legible. No analyst has yet asked Duffy about FMX publicly.
Cantor/Lutnick related-party governance creates a persistent discount. BGC compressed FROM 9-11x TO 7x WHILE FMX gained share — the discount widened, not narrowed, despite improving asset quality. Sell-side cannot model "Cantor satellite reorganization" as a numeric input.
Risks (ranked)
- Governance discount is structural. If 7x is fair value for Cantor satellites, rerate caps at 9x not 12x. Pre-FMX 9-11x was the equilibrium. Bull case bounded.
- FMX consortium collective action. 12 banks back FMX with $172M equity; each also benefits from CME cross-margining. Defection risk on any single name.
- CMESC launches Q3 2026. Would kill the regulatory windfall narrative.
- Hormuz vol normalizes. CME Q1 metals/energy windfall doesn't repeat in Q2; turnover decels.
- Print misses. FMX UST ADV <$58B in Q1 → thesis breaks, stop $9.50.
Catalysts
- May 1, 2026: Tradeweb April monthly volume + ICE Q1 earnings (Treasury Clearing volumes)
- May 7, 2026: BGC Q1 earnings — FMX UST ADV print (binary)
- Jul 31, 2026: CME Q2 10-Q (BrokerTec UST continuation test)
- Dec 31, 2026: SEC clearing mandate deadline
What Would Change Our Mind
- FMX UST ADV in Q1 < $58B → thesis broken
- Tradeweb April UST growth < +10% YoY → market structure shift questionable
- 8-K announcing major bank pulling from FMX consortium
- SEC delays clearing mandate ≥6 months
- Lutnick/Cantor governance event (SEC inquiry, related-party scandal)
- Empirical study of BGC pre-FMX P/E history shows 7-8x was the historical mean (governance discount permanent)
Evidence
| Evidence | Source | Credibility | LR |
|---|---|---|---|
| BGC Q1 outlook beat guidance high end ($222M+ PBT); FMX called "world's fastest growing UST platform" | BGC 8-K 2026-03-26 | 0.95 | 1.6 |
| Tradeweb US gov bond ADV +24.4% YoY March 2026 ($310.1B record) vs CME BrokerTec UST -3.4% Q1 = 28pp spread in same market | Tradeweb monthly volume release + CME 10-Q 2026-04-24, BrokerTec data | 0.95 | 1.5 |
| CME BrokerTec UST cash CLOB ADV -3.4% YoY in HIGH-VOL Q1 ($107.9B vs $111.7B); 3rd consecutive decline | CME 10-Q 2026-04-24, Cash Markets section | 0.95 | 1.4 |
| CME Q1 2026 earnings call: FMX mentioned zero times — 5th consecutive call without acknowledgment | CME Q1 2026 earnings call transcript | 0.95 | 1.3 |
| ICE Clear Credit UST cash clearing operational Feb 3, 2026 — beats CMESC by 11+ months on SEC mandate deadline | ICE 10-K 2026-02-05 | 0.95 | 1.2 |
| Duffy on Q1 call re CMESC: "Sometimes you hear folks say this could be delayed — that's not a surprise" | CME Q1 2026 earnings call Q&A | 0.95 | 1.1 |
| CME Q1 2026 record results (+14.5% revenue, +18% op income, 69.7% margin) — moat partially intact | CME 10-Q 2026-04-24, MD&A | 0.95 | 0.85 |
| Cross-ticker analog: regulatory/contractual moats held in 4/4 resolved tech disruption cases | Worldview cross-ticker analysis | 0.85 | 0.7 |
// comments (0)